Author:
Dai ChuanYun,Fu Ya,Chen ShaoCheng,Li Biao,Yao Bo,Liu WanHong,Zhu LiQing,Chen Nan,Chen Ji,Zhang Qiang
Publisher
Springer Science and Business Media LLC
Subject
General Agricultural and Biological Sciences,General Environmental Science,General Biochemistry, Genetics and Molecular Biology
Reference31 articles.
1. Chapman P B, Lester T J, Casper E S, et al. Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer. J Clin Oncol, 1987, 5: 1942–1951
2. Maeda H. SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy. Adv Drug Deliver Rev, 2001, 46: 169–185
3. Blick M, Sherwin S A, Rosenblum M, et al. Phase I study of recombinant tumor necrosis factor in cancer patients. Cancer Res, 1987, 47: 2986–2989
4. Harris J M, Chess R B. Effect of PEGylation on pharmaceuticals. Nat Rev Drug Discov, 2003, 2: 214–221
5. Tsutsumi Y, Kihira T, Tsunoda S, et al. Molecular design of hybrid tumour necrosis factor alpha with polyethylene glycol increases its anti-tumour potency. Br J Cancer, 1995, 71: 963–968
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献